Rheugesic 20 mg Dispersible Tablet
PDF Leaflet Revision Date: 07 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Emergency treatment of acute gout attacks and post-traumatic conditions.
Dosage (summary)
20 mg daily for a maximum of 5 days.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Asthma
Pregnancy & Breastfeeding
Safety not established; may cause serious fetal complications.
Key Drug Interactions
- Coumarin anticoagulants
- Aspirin sensitivity
Contraindications
- Gastro-intestinal haemorrhage
- Active peptic ulceration
- Hypersensitivity to piroxicam
Common side effects
- Gastro-intestinal disturbance
- Headache
- Dizziness
- Nausea
- Vomiting
Counselling Points
- Take with food to minimize GI upset
- Do not exceed 5 days of treatment
- Report any vision changes
Serious warnings
- Risk of renal dysfunction
- Serious gastro-intestinal bleeding
Important Disclaimer
The Rheugesic 20 mg Dispersible Tablet professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
